Correlation Between Innovation1 Biotech and Cannabics Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovation1 Biotech and Cannabics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovation1 Biotech and Cannabics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovation1 Biotech and Cannabics Pharmaceuticals, you can compare the effects of market volatilities on Innovation1 Biotech and Cannabics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovation1 Biotech with a short position of Cannabics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovation1 Biotech and Cannabics Pharmaceuticals.

Diversification Opportunities for Innovation1 Biotech and Cannabics Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Innovation1 and Cannabics is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Innovation1 Biotech and Cannabics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabics Pharmaceuticals and Innovation1 Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovation1 Biotech are associated (or correlated) with Cannabics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabics Pharmaceuticals has no effect on the direction of Innovation1 Biotech i.e., Innovation1 Biotech and Cannabics Pharmaceuticals go up and down completely randomly.

Pair Corralation between Innovation1 Biotech and Cannabics Pharmaceuticals

If you would invest  1.00  in Cannabics Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Cannabics Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Innovation1 Biotech  vs.  Cannabics Pharmaceuticals

 Performance 
       Timeline  
Innovation1 Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovation1 Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Innovation1 Biotech is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Cannabics Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabics Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent fundamental drivers, Cannabics Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Innovation1 Biotech and Cannabics Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovation1 Biotech and Cannabics Pharmaceuticals

The main advantage of trading using opposite Innovation1 Biotech and Cannabics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovation1 Biotech position performs unexpectedly, Cannabics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabics Pharmaceuticals will offset losses from the drop in Cannabics Pharmaceuticals' long position.
The idea behind Innovation1 Biotech and Cannabics Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges